D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 87,500
-5,000 (-5.41%)
Jun 30, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 4.11 trillion as of June 30, 2026. Its market cap has increased by 346.57% in one year.
Market Cap
4.11T
Enterprise Value
4.09T
Revenue
3.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
87,500.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 4.11T, an increase of 982.38%. That is a compound annual growth rate of 201.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 4.11T | 2.80% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 10.61T |
| Kolon TissueGene | 8.09T |
| SK Biopharmaceuticals | 6.49T |
| HLB Co., Ltd. | 6.34T |
| LigaChem Biosciences | 5.27T |
| Peptron | 3.89T |
| Voronoi | 3.07T |
| SK bioscience | 2.74T |